| 2026-08-05 | 10-Q | 10.1 | Amendment to Employment Agreement, dated as of August 3, 2026, by and between ADMA Biologics, Inc. and Paul Terence Kohler, Jr. |
|---|
| 2026-02-25 | 8-K | 10.2 | Employment Agreement, dated November 25, 2025, by and between ADMA Biologics, Inc. and Paul Terence Kohler, Jr. |
|---|
| 2026-02-25 | 8-K | 10.1 | Separation Agreement and Release, and Consulting Services Agreement attached as Exhibit A thereto, each dated as of February 25, 2026, by and between ADMA Biologics, Inc. and Brad Tade |
|---|
| 2025-08-06 | 8-K | 10.1 | Credit Agreement, dated as of August 5, 2025, by and among ADMA Biologics, Inc., as Borrower, the other Loan Parties party thereto, the Lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent. |
|---|
| 2025-03-18 | 10-K | 10.11 | Form of Indemnification Agreement. |
|---|
| 2025-03-18 | 10-K | 10.8 | Plasma Purchase Agreement, effective as of August 6, 2024, by and between KEDPlasma LLC and ADMA BioManufacturing, LLC. |
|---|
| 2025-03-18 | 10-K | 10.7 | Amended and Restated Plasma Purchase Agreement, effective as of October 1, 2024, by and between Grifols Worldwide Operations Limited and ADMA BioManufacturing, LLC. |
|---|
| 2024-07-26 | 8-K | 10.1 | Employment Agreement, dated July 24, 2024, by and between the Company and Brad Tade. |
|---|
| 2024-04-02 | 8-K | 10.1 | Employment Agreement, dated April 1, 2024, by and between the Company and Kaitlin Kestenberg. |
|---|
| 2024-02-28 | 8-K | 10.1 | Consulting Agreement, dated February 27, 2024, by and between the Company and Mr. Brian Lenz. |
|---|
| 2023-12-18 | 8-K | 10.2 | Security Agreement, dated as of December 18, 2023, by and among ADMA Biologics, Inc., ADMA BioManufacturing, LLC, ADMA Plasma Biologics, Inc. and ADMA BioCenters Georgia, Inc., as Grantors, and Ares Capital Corporation, as Collateral Agent. |
|---|
| 2023-12-18 | 8-K | 10.1 | Credit Agreement, dated as of December 18, 2023, by and among ADMA Biologics, Inc., as Administrative Borrower, ADMA BioManufacturing, LLC, ADMA Plasma Biologics, Inc. and ADMA BioCenters Georgia Inc., each as Borrowers, certain subsidiaries of ADMA Biologics, Inc., as Guarantors, from time to time party thereto, the Lenders from time to time party thereto, Ares Capital Corporation, as Administrative Agent and as Collateral Agent, and ACF FINCO I LP, as Revolving Agent. |
|---|
| 2023-05-02 | 8-K | 10.1 | Amendment No. 2 to the Credit and Guaranty Agreement, dated as of May 1, 2023 |
|---|
| 2023-03-23 | 10-K | 10.25-1 | Amendment No. 1 to Credit Agreement and Guaranty, dated March 23, 2023 by and among the Company, Hayfin Services LLP and the lenders party thereto. |
|---|
| 2022-11-09 | 10-Q | 10.1 | Amendment 4 to the Amended and Restated Agreement For Services Between ADMA BioManufacturing, LLC and Areth LLC. |
|---|
| 2022-06-21 | 8-K | 10.1 | ADMA Biologics, Inc. 2022 Equity Compensation Plan |
|---|
| 2022-03-24 | 10-K | 10.25 | Security Agreement, dated as of March 23, 2022, by and among the Company, certain subsidiaries of the Company and Hayfin Services LLP. |
|---|
| 2022-03-24 | 10-K | 10.24 | Credit Agreement and Guaranty, dated as of March 23, 2022, by and among the Company, Hayfin Services LLP and the lenders party thereto |
|---|
| 2021-10-01 | 8-K | 10.3 | Amendment to Employment Agreement, dated as of September 29, 2021, by and between the Company and Brian Lenz. |
|---|
| 2021-10-01 | 8-K | 10.2 | Amendment to Employment Agreement, dated as of September 29, 2021, by and between the Company and Adam Grossman. |
|---|
| 2021-10-01 | 8-K | 10.1 | Form of Retention Bonus Agreement |
|---|
| 2021-08-11 | 10-Q | 10.2 | Separation Agreement and Release, dated August 6, 2021, by and between ADMA Biologics, Inc. and James Mond. |
|---|
| 2021-05-12 | 10-Q | 10.1 | Second Amendment to Plasma Purchase Agreement, effective as of May 12, 2021, by and between ADMA BioManufacturing, LLC and Grifols Worldwide Operations LTD |
|---|
| 2020-12-09 | 8-K | 10.1 | Amendment No. 2 to Credit Agreement and Guaranty, dated December 8, 2020 |
|---|
| 2020-03-13 | 10-K | 10.27 | Amendment 3 to the Amended and Restated Agreement for Services, effective as of November 7, 2019, by and between ADMA Biologics, LLC and Areth LLC. |
|---|
| 2020-03-13 | 10-K | 10.26 | Amendment 2 to the Amended and Restated Agreement for Services, effective as of September 27, 2018, by and between ADMA Biologics, LLC and Areth LLC. |
|---|
| 2020-03-13 | 10-K | 10.25 | Amendment 1 to the Amended and Restated Agreement for Services, effective as of September 25, 2017, by and between ADMA Biologics, LLC and Areth LLC. |
|---|
| 2019-09-05 | 8-K | 10.1 | Amendment #1 to Transition Services Agreement, dated as of August 29, 2019, by and between ADMA Biomanufacturing, LLC and Biotest Pharmaceuticals Corporation. |
|---|
| 2019-05-03 | 8-K | 10.1 | Amendment No. 1 to Credit Agreement and Guaranty, dated as of May 3, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC and Perceptive Credit Holdings II, LP. |
|---|
| 2019-03-13 | 10-K | 10.22 | Transition Services Agreement, dated as of January 1, 2019, by and between the Company and Biotest Pharmaceuticals Corporation. |
|---|
| 2019-02-12 | 8-K | 10.2 | Security Agreement, dated as of February 11, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, and Perceptive Credit Holdings II, LP. |
|---|
| 2019-02-12 | 8-K | 10.1 | Credit Agreement and Guaranty, dated as of February 11, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, and Perceptive Credit Holdings II, LP. |
|---|
| 2019-01-29 | 8-K | 10.3 | Amended and Restated Employment Agreement, dated as of January 29, 2019, by and between ADMA Biologics, Inc. and Brian Lenz. |
|---|
| 2019-01-29 | 8-K | 10.2 | Amended and Restated Employment Agreement, dated as of January 29, 2019, by and between ADMA Biologics, Inc. and Dr. James Mond. |
|---|
| 2019-01-29 | 8-K | 10.1 | Amended and Restated Employment Agreement, dated as of January 29, 2019, by and between ADMA Biologics, Inc. and Adam Grossman. |
|---|
| 2019-01-02 | 8-K | 10.1 | Fifth Amendment to Plasma Purchase Agreement, effective as of January 1, 2019, by and between ADMA Biologics, Inc. and Grifols Worldwide Operations Limited. |
|---|
| 2018-08-10 | 10-Q | 10.3 | Amendment to Plasma Purchase Agreement, dated as of July 19, 2018, by and between Biotest Pharmaceuticals Corporation and ADMA BioManufacturing, LLC. |
|---|
| 2018-08-10 | 10-Q | 10.2 | Amendment #1 to the Plasma Supply Agreement, dated as of July 19, 2018, by and between Biotest Pharmaceuticals Corporation and ADMA BioManufacturing, LLC. |
|---|
| 2018-08-10 | 10-Q | 10.1 | Share Transfer, Amendment and Release Agreement, dated as of May 14, 2018, by and among Biotest Pharmaceuticals Corporation, Biotest AG, The Biotest Divestiture Trust, Biotest US Corporation, ADMA BioManufacturing, LLC, ADMA Biologics, Inc. and ADMA Bio Centers Georgia Inc. |
|---|
| 2018-07-24 | 8-K | 10.2 | Agreement to Transfer Land, dated as of July 20, 2018, by and among Biotest Real Estate Corp., Biotest AG, Biotest Pharmaceuticals Corporation, ADMA BioManufacturing, LLC and ADMA Biologics, Inc. |
|---|
| 2018-07-24 | 8-K | 10.1 | Assignment and Assumption Agreement (ADMA Loan), dated as of July 20, 2018, by and among Biotest AG, Biotest Pharmaceuticals Corporation, ADMA BioManufacturing, LLC and ADMA Biologics, Inc. |
|---|
| 2018-03-29 | 10-K | 10.24.2 | Amendment #3 to the Manufacturing Agreement, effective as of December 21, 2017, by and between ADMA BioManufacturing, LLC and Sanofi Pasteur S.A. |
|---|
| 2018-03-29 | 10-K | 10.24.1 | Amendment #2 to the Manufacturing Agreement, effective as of August 1, 2016, by and between ADMA BioManufacturing, LLC (as successor-in-interest to Biotest Pharmaceuticals Corporation) and Sanofi Pasteur S.A. |
|---|
| 2018-03-29 | 10-K | 10.24 | Manufacturing Agreement, dated as of September 30, 2011, by and between ADMA BioManufacturing, LLC (as successor-in-interest to Biotest Pharmaceuticals Corporation) and Sanofi Pasteur S.A. |
|---|
| 2017-10-11 | 8-K | 10.4 | Pledge Agreement, dated as of October 10, 2017, by and between the Company and Wilmington Trust, National Association. |
|---|
| 2017-10-11 | 8-K | 10.3 | Intellectual Property Security Agreement, dated as of October 10, 2017, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC and Wilmington Trust, National Association. |
|---|
| 2017-10-11 | 8-K | 10.2 | Security Agreement, dated as of October 10, 2017, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC and Wilmington Trust, National Association. |
|---|
| 2017-10-11 | 8-K | 10.1 | Credit Agreement, dated as of October 10, 2017, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, Marathon Healthcare Finance Fund, L.P. and Wilmington Trust, National Association. |
|---|
| 2017-08-11 | 10-Q | 10.10 | Termination Agreement (Manufacturing, Supply and License Agreement and Master Services Agreement), dated as of June 6, 2017, by and between the Company and Biotest Pharmaceuticals Corporation. |
|---|
| 2017-08-11 | 10-Q | 10.9 | Fourth Amendment to Plasma Purchase Agreement, dated as of June 6, 2017, by and between the Company and Biotest Pharmaceuticals Corporation. |
|---|
| 2017-08-11 | 10-Q | 10.8 | First Amendment to License Agreement, dated as of June 6, 2017, by and between the Company and Biotest Aktiengesellschaft. |
|---|
| 2017-08-11 | 10-Q | 10.7 | Purchase Agreement, dated as of June 6, 2017, by and among the Company, Biotest Pharmaceuticals Corporation and ADMA Bio Centers Georgia, Inc. |
|---|
| 2017-08-11 | 10-Q | 10.6 | Plasma Purchase Agreement, dated as of June 6, 2017, by and between ADMA BioManufacturing, LLC and Biotest Pharmaceuticals Corporation. |
|---|
| 2017-08-11 | 10-Q | 10.5 | Plasma Supply Agreement, dated as of June 6, 2017, by and between ADMA BioManufacturing, LLC and Biotest Pharmaceuticals Corporation. |
|---|
| 2017-08-11 | 10-Q | 10.4 | Transition Services Agreement, dated as of June 6, 2017, by and between ADMA BioManufacturing, LLC and Biotest Pharmaceuticals Corporation. |
|---|
| 2017-06-12 | 8-K | 10.3 | Registration Rights Agreement, dated as of June 6, 2017, by and between the Company and Seller |
|---|
| 2017-06-12 | 8-K | 10.2 | Stockholders Agreement, dated as of June 6, 2017, by and between the Company and Seller. |
|---|
| 2017-06-12 | 8-K | 10.1 | Subordinated Loan Agreement, dated as of June 6, 2017, by and among the Company, Buyer and Seller. |
|---|
| 2017-02-24 | 10-K | 10.22 | Lease, effective as of February 17, 2017, by and between Home Center Properties, LLC and ADMA Bio Centers Georgia Inc. |
|---|
| 2016-08-12 | 10-Q | 10.18 | Amended and Restated Agreement for Shared Services Agreement, between ADMA Biologics, Inc. and Areth LLC. |
|---|
| 2016-05-13 | 10-Q | 10.17.1 | First Amendment to Loan and Security Agreement with Oxford Finance LLC, dated May 13, 2016. |
|---|
| 2016-05-13 | 10-Q | 10.3.2 | Biotest 3rd Amendment to Plasma Purchase Agreement. |
|---|
| 2016-03-23 | 10-K | 10.11 | Amended and Restated Employment Agreement, dated January 28, 2016, by and between ADMA Biologics, Inc. and James Mond |
|---|
| 2016-03-23 | 10-K | 10.10 | Amended and Restated Plasma Supply Agreement, dated March 23, 2016, between ADMA Biologics, Inc. and Biotest Pharmaceuticals Corporation |
|---|
| 2016-03-23 | 10-K | 10.8 | Amended and Restated Employment Agreement, dated January 28, 2016, by and between ADMA Biologics, Inc. and Brian Lenz |
|---|
| 2016-03-23 | 10-K | 10.3.1 | Amendment No. 2 to Plasma Purchase Agreement, as amended, dated December 18, 2015, between Biotest Pharmaceuticals Corporation and ADMA Biologics, Inc. |
|---|
| 2016-03-23 | 10-K | 10.2 | Amended and Restated Employment Agreement, dated January 28, 2016, by and between ADMA Biologics, Inc. and Adam Grossman |
|---|
| 2015-08-11 | 10-Q | 10.23 | Loan and Security Agreement, dated as of June 19, 2015, among Oxford Finance LLC, the Lenders listed therein, and ADMA Biologics Inc. |
|---|
| 2015-05-12 | 10-Q | 10.1 | Amendment No. 2, dated March 25, 2015, to the Plasma Supply Agreement, dated June 22, 2012, between ADMA Biologics, Inc. and Biotest Pharmaceuticals Corporation |
|---|
| 2014-03-28 | 10-K | 10.20.1 | First Amendment to Loan and Security Agreement, dated as of February 24, 2014, by and among ADMA Biologics, Inc., ADMA Plasma Biologics, Inc., ADMA BioCenters Georiga Inc. and Hercules Technology Growth Capital, Inc. |
|---|
| 2014-03-28 | 10-K | 10.18 | Amendment No. 1, dated February 25, 2014, to the Plasma Supply Agreement, dated June 22, 2012, between ADMA Biologics, Inc. and Biotest Pharmaceuticals Corporation |
|---|
| 2014-03-28 | 10-K | 10.12 | Agreement of Lease, dated as of January 20, 2014, between ADMA BioCenters Georgia, Inc. and U.S. Bank National Association, as trustee, effective February 1, 2014, for the premises located in Marietta, Georgia |
|---|
| 2012-06-22 | 8-K/A | 10.9 | Plasma Purchase Agreement, dated as of November 17, 2011, between Biotest Pharmaceuticals Corporation and ADMA Biologics, Inc., as amended |
|---|
| 2012-06-22 | 8-K/A | 10.8 | Manufacturing Agreement, dated as of October 23, 2006, by and between Biotest Pharmaceuticals Corporation and ADMA Biologics, Inc., as amended |
|---|
| 2012-06-21 | 8-K | 10.1 | Placement Agency Modification and Release Agreement |
|---|
| 2012-05-03 | 8-K | 10.1 | Employment Agreement, dated as of April 30, 2012, by and between ADMA Biologics, Inc. and Brian Lenz. |
|---|
| 2012-03-29 | 8-K/A | 10.10 | Agreement for Services between the Company and Areth Inc., dated July 23, 2007. |
|---|
| 2012-03-29 | 8-K/A | 10.5 | Form of Lockup Agreement |
|---|
| 2012-03-29 | 8-K/A | 10.1 | 2007 Employee Stock Option Plan (as amended) |
|---|
| 2012-02-13 | 8-K | 10.12 | Form of Indemnification Agreement |
|---|
| 2012-02-13 | 8-K | 10.11 | Agreement of Lease between the Company and C1VF I-GA1W15-W23, LLC (DCT Holdings), effective June 1, 2008 and confirmed on November 13, 2008, for the premises located at 6290 Jimmy Carter Boulevard, Suite 206-208, Norcross, Georgia. |
|---|
| 2012-02-13 | 8-K | 10.10 | Agreement for Services between the Company and Areth Inc., dated July 23, 2007. |
|---|
| 2012-02-13 | 8-K | 10.9 | Plasma Purchase Agreement, dated as of November 17, 2011, between Biotest Pharmaceuticals Corporation and ADMA Biologics, Inc. |
|---|
| 2012-02-13 | 8-K | 10.8 | Manufacturing Agreement, dated as of October 23, 2006, by and between Biotest Pharmaceuticals Corporation and ADMA Biologics, Inc., as amended |
|---|
| 2012-02-13 | 8-K | 10.7 | Investors’ Rights Agreement, dated July 17, 2007, by and among the Company and each of the investors listed on Schedule A thereto |
|---|
| 2012-02-13 | 8-K | 10.6 | Employment Agreement, dated February 13, 2012, by and between ADMA Biologics, Inc. and Adam Grossman |
|---|
| 2012-02-13 | 8-K | 10.5 | Form of Lockup Agreement |
|---|
| 2012-02-13 | 8-K | 10.4 | Amended and Restated Placement Agency Agreement, dated February 12, 2012, between ADMA Biologics, Inc. and Rodman & Renshaw, LLC |
|---|
| 2012-02-13 | 8-K | 10.3 | Form of Registration Rights Agreement, dated as of February 13, 2012, between R&R Acquisition VI, Inc. and each of the several purchasers signatory thereto |
|---|
| 2012-02-13 | 8-K | 10.2 | Form of Securities Purchase Agreement, dated as of February 13, 2012, between ADMA Biologics, Inc. and each purchaser identified on the signature pages thereto |
|---|
| 2012-02-13 | 8-K | 10.1 | 2007 Employee Stock Option Plan (as amended) |
|---|
| 2009-04-27 | 10-Q | 10.1 | Occupancy Agreement between R&R Acquisition VI, Inc. and Kirk M. Warshaw, LLC |
|---|